https://www.marketscreener.com/quote/stock/ALTERITY-THERAPEUTICS-LIM-57291688/news/Alterity-Therapeutics-Limited-Doses-the-First-Participant-in-the-U-S-in-Phase-2-Clinical-Trial-of-A-43278885/?utm_source=telegram&utm_medium=social&utm_campaign=share